Attenuating ETEC virulence using a heat-labile enterotoxin–blocking binding protein
Authors:
- Marcus PeterssonMPMarcus Petersson
- Jens Sivkær PettersenJPJens Sivkær Pettersen
- Ágnes DuzsÁDÁgnes Duzs
- Monica L. Fernández-QuinteroMFMonica L. Fernández-Quintero
- Nick Jean BurletNBNick Jean Burlet
- Ute KrengelUKUte Krengel
- Timothy P. JenkinsTimothy P. Jenkins
- Andrew B. WardAWAndrew B. Ward
- Thomas Emil AndersenTAThomas Emil Andersen
- Jakob Møller-JensenJMJakob Møller-Jensen
Open Access
- 19 December 2025
- journal article
- Published by Taylor & Francis in Gut Microbes
- Vol. 18 (1) , 2597567
Abstract
Bacterial enteric pathogens are major contributors to the global burden of diarrheal diseases and the associated consequences for human health including malnutrition, growth stunting, morbidity, and mortality. While mortality from diarrhea has decreased, incidence remains high, and better interventions for preventing disease are needed. Single-domain antibodies (i.e., VHHs), functioning as target-binding proteins in the gastrointestinal tract, have been proposed as a potential approach to mitigate bacterial pathogenesis. Here, we describe a mitigation strategy where precision binding of a bivalent VHH to the receptor-binding B-pentamer of heat-labile enterotoxin aggregates the AB5 toxin and impairs enterotoxigenic Escherichia coli colonization in a flow chamber model simulating the human intestine. The VHH construct also binds to the structurally similar cholera toxin and effectively abrogates its intestinal cell cytotoxicity in vitro. Based on these results, we believe that targeting virulence could emerge as a new strategy for the management of bacterial enteric pathogens, supporting gut health in at-risk populations alongside vaccination campaigns or in populations without access to vaccines.Keywords
Funding Information
- Innovationsfonden (1061-00010A)
- Mica Foundation
- Norwegian INFRASTRUKTUR-program (project no. 245828)
- Innovation Fund Denmark (1044-00106B)
- Universitetet i Oslo
This publication has 116 references indexed in Scilit:
- Allergenicity, Genotoxicity and Subchronic Toxicity Assessment of IgG Binding Protein LT Produced From Aspergillus oryzaeJournal of Applied Toxicology, 2025
- Fit‐for‐purpose heterodivalent single‐domain antibody for gastrointestinal targeting of toxin B fromClostridium difficileProtein Science, 2024
- An overview of the Amber biomolecular simulation packageWIREs Computational Molecular Science, 2012
- Enhancement of toxin- and virus-neutralizing capacity of single-domain antibody fragments by N-glycosylationApplied Microbiology and Biotechnology, 2009
- The Influence of Ligand Valency on Aggregation Mechanisms for Inhibiting Bacterial ToxinsChemBioChem, 2009
- Strong Inhibition of Cholera Toxin by Multivalent GM1 DerivativesChemBioChem, 2007
- Properties, production, and applications of camelid single-domain antibody fragmentsApplied Microbiology and Biotechnology, 2007
- Characterization of the binding of cholera toxin to ganglioside GM1 immobilized onto microtitre platesJournal of Applied Toxicology, 2005
- Simple method of purification of Escherichia coli heat-labile enterotoxin and cholera toxin using immobilized galactoseMicrobial Pathogenesis, 1994
- Evolution and structure of two ADP‐ribosylation enterotoxins, Escherichia coli heat‐labile toxin and cholera toxinFEBS Letters, 1984